INTRODUCTION {#s1}
============

Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting the basal ganglia and causing the degeneration of dopaminergic neurons[@r1]^)^ resulting in bradykinesia, resting tremor, rigidity of muscles, and impaired posture[@r2]^)^. Impairments in limb function, gait, balance, speech, mobility, and activities of daily living significantly affect the quality of life in people with PD. While people with PD perceive their movement as normal, they often present with abnormally small amplitude movement[@r3]^)^. Several treatment approaches to address this movement disorder including visual, auditory and self-cuing are associated with normalizing movement amplitude temporarily, but no definitive long term solutions have been developed to date[@r4]^)^. Even with dopaminergic medication, gait and balance impairments persist, contributing to increased fall risk[@r5], [@r6]^)^. In one systematic review, it was reported that an average of 60.5% of people with PD reported at least one fall, and 39% reported recurrent falls[@r7]^)^. Physical therapy is an integral part of PD treatment, focusing on gait training, balance training, and fall prevention as hallmark interventions[@r5], [@r8]^)^. Lee Silverman Voice Treatment (LSVT) BIG^®^ is an exercise and self-cuing based physical or occupational therapy treatment derived from the speech treatment, LSVT LOUD^®^ which is utilized in the treatment of speech deficits including hypophonia. LSVT LOUD has demonstrated short-term and 2 year long-term retention of improvements in loudness and is now considered an evidence-based treatment in people with PD[@r3], [@r9]^)^. LSVT BIG is designed to decrease the impact of hypokinesia on the functional mobility of people with PD by encouraging patients to move using powerful, large amplitude movements during progressive, high intensity training[@r10]^)^. The goal of LSVT BIG is to restore normal movement amplitude by recalibrating the patient's perception of movement execution[@r3]^)^. One unique aspect of LSVT BIG's treatment protocol is its emphasis on key principles associated with motor learning, including high intensity, salience, multiple repetitions, and progressive complexity[@r11], [@r12]^)^. These principles may help to facilitate activity dependent motor learning and neuroplasticity to enhance the generalizability and automaticity of movement[@r12]^)^. This emphasis maximizes a client's ability to develop, consolidate, and generalize self-cuing skills to the point that they transfer into more effective real world function[@r13], [@r14]^)^. Previous studies have suggested that LSVT BIG improves gait speed, mobility, TUG performance, and other functional measures[@r1],[@r2],[@r3], [@r10]^)^.

An overwhelming majority of people with PD demonstrate a deterioration of their functional ability while performing two (dual) or more tasks simultaneously[@r8]^)^. Dual task conditions exacerbate gait impairments and result in added mobility deficits including reduced gait speed and decreased coordination[@r15]^)^. It has been suggested that people with PD may adopt a strategy that focuses a majority of their attention on the concurrent cognitive task and less attention to the mobility task during dual task activities, thus increasing fall risk[@r16]^)^. Several interventions have been proposed to improve dual task performance, such as rhythmic auditory cueing, attentional strategies, treadmill training, and task specific training[@r5], [@r6], [@r17],[@r18],[@r19],[@r20],[@r21]^)^. LSVT BIG may be another viable intervention to improve dual task walking and mobility. The existing literature examining LSVT BIG suggests that this approach to treatment has a positive impact on PD related movement disorders including hypokinesia and bradykinesia while performing single tasks[@r12]^)^. We hypothesize that these decreases in the negative impact of movement disorders should transfer to tasks performed in dual task conditions if the cueing strategies used in LSVT BIG are learned to the point that they do not require substantial conscious attention. While LSVT BIG has not been specifically designed to address dual task abilities, we believe that the emphasis on learning to use the internal cueing strategies taught during LSVT BIG treatment to the point that they are used automatically serves to facilitate their incorporation during the performance of two concurrent tasks. However, there are no published studies examining the impact of LSVT BIG treatment on dual task performance. To initiate the testing of this overarching hypothesis, this retrospective cohort study was performed to examine the initial hypothesis that LSVT BIG intervention may decrease the negative impact of performing a second task on the speed of mobility in persons with PD.

SUBJECTS AND METHODS {#s2}
====================

The Institutional Review Board of JFK Johnson Rehabilitation Institute, where 100% of the studied patient encounters occurred, deemed this study exempt from human subjects consideration because all data utilized were collected as part of the patients' routine clinical care. Criteria for referral to the LSVT BIG treatment program included: 1) diagnosis of PD, 2) written referral from their physician, 3) ambulatory with or without an assistive device, and 4) stable on PD medications. Contraindications for LSVT BIG intervention included: 1) unstable blood pressure, 2) osteoporosis, and/or 3) other comorbidities that influenced their ability to engage in physical activity for 1 hour. Inclusion criteria for data analysis included: 1) completion of at least 14 of the 16 scheduled LSVT BIG treatment sessions and 2) medical records that included pre- treatment and post-treatment scores for the Timed Up and Go Test (TUG), the TUG motor test (TUG MOTOR), and the TUG cognitive test (TUG COG). The records of 114 patients diagnosed with PD who participated in the LSVT BIG program at JFK Johnson Rehabilitation Institute, an outpatient rehabilitation department of a suburban hospital, were reviewed for this retrospective cohort study. The data of 93 subjects that met all inclusion criteria for treatment and data analysis were extracted (54 males, 39 females; mean age, 68.4 ± 10.6; mean PD duration, 4.9 ± 5.3 years).

The treating physical therapist evaluated each patient prior to the start of LSVT BIG intervention and again after completion of the last treatment. Data was collected for the TUG, TUG MOTOR, and TUG COG outcome measures. The TUG has been previously established as valid and reliable tool to assess patients with PD both within and between practitioners[@r22],[@r23],[@r24]^)^. For the TUG, participants were required to stand up from a seated position in a chair, walk 3 meters at their optimal walking speed, turn around, walk back to the chair and sit down. The time taken to complete the task was measured with a stopwatch[@r25]^)^. This test has been demonstrated to be valid and reliable in persons with PD to detect change and indicate fall risk[@r26]^)^ and an established cutoff score of greater than 11.5 seconds has been indicative of increased risk for falls in persons with PD[@r27]^)^. For the TUG MOTOR, participants completed the TUG described above while simultaneously carrying a cup of water[@r28]^)^. The time taken to complete the task has been suggested to correlate to the level of functional mobility[@r29]^)^. For the TUG COG, participants completed the TUG while simultaneously reciting the days of the week in backwards order[@r30], [@r31]^)^. This approach, which has been validated for persons with PD[@r30]^)^, deviates from the original testing protocol described by Shumway Cook and Woollcott, who recommended that clients be instructed to count backwards by threes or to recite alternate letters of the alphabet aloud[@r29],[@r30],[@r31],[@r32]^)^.

The LSVT BIG intervention has previously been described in detail[@r11], [@r12]^)^. It consists of 16, one hour treatment sessions (4 sessions per week for 4 weeks) in clinic, one on one with an LSVT BIG certified therapist, and one to two home practice sessions per day lasting 15−20 minutes each. During all activities, patients are instructed to perform large amplitude movements with near maximal effort and the most efficient biomechanics available. Initially, when smaller amplitude or lower effort movements are observed the therapist immediately cues the patient to increase, or the activity is modified. As treatments progress, participants are encouraged to self-monitor their effort and amplitude with the goal of completing this accurately and independently[@r11]^)^.

The first part of each clinic session and all home practice sessions incorporates seven standardized whole-body movements which combine stepping, weight shifting and reaching movements in multiple directions as well as sustained holds. The second portion of each session includes five simple every day functional activities (e.g. sit to stand, rolling in bed) that the patient has identified as needing improvement. This is followed by walking with larger amplitude movements and posture. Finally whole, multi-step task practice follows. These tasks are complex functional activities that are directly related to the patient's goals and scaled to the patient's current ability level. They are progressed over the course of treatment by increasing task complexity or difficulty or by adding a concurrent task.

As stated above, subjects were also instructed to engage in ten, 15--20 minute bouts of a home exercise program each week (one home exercise bout each treatment day and two bouts on the other three days). These home exercise sessions included the standardized exercises, functional component tasks, walking and a daily carryover assignment designed to emphasize the use of LSVT BIG strategies in daily activities[@r12]^)^.

All statistical analyses were conducted using Minitab 18™. TUG, TUG MOTOR, and TUG COG scores preceding and following LSVT BIG treatment were compared using paired t-tests. Statistical significance was accepted for values of p\<0.05. Dual task cost (DTC) was calculated by dividing the difference between TUG MOTOR or TUG COG times and the TUG time collected the same day and then dividing by the TUG score (TUG Cog − TUG) / TUG[@r33]^)^. For further analyses, TUG and TUG COG change scores were z-normalized to eliminate the impact of score magnitude on interpretation of relative change between these two constructs. Dual task cost is a measure of the impact of performing a second task on performance of a reference task. We chose to consider this measure because the ability to perform two tasks simultaneously is impaired and correlated with quality of life as well as safety in persons with PD[@r8]^)^. It is particularly useful when comparing patients with a wide variety of mobility levels because it normalizes the impact of the second task with baseline mobility levels[@r15]^)^. This flexibility was useful considering the heterogeneity of initial TUG performances demonstrated by our sample.

RESULTS {#s3}
=======

Demographic data and outcome measures at baseline and after LSVT BIG intervention are reported in [Table 1](#tbl_001){ref-type="table"}Table 1.Demographic data and functional outcome measure scores, at baseline and post LSVT BIG treatmentPre LSVT BIG treatment n=93Post LSVT BIG treatmentEffect size (Hedge's g)Age (years)68.4 ± 10.6------Gender (M/F)54/39------Duration of PD (years)4.9 ± 5.3------Falls in the past 6 months (%)17.2%------TUG test (seconds)13.2 ± 6.99.94 ± 3.53\*\*0.59 (0.40--0.78)TUG Cognitive test (seconds)16.3 ± 10.511.5 ± 6.1\*\*0.55 (0.42--0.72)TUG Motor test (seconds)16.0 ± 9.811.7 ± 5.1\*\*0.55 (0.38--0.72)TUG Cog cost21.6%14.9%\*TUG Motor cost21.8%17.8%Values represent mean ± SD.\*Statistically significant difference (p\<0.05).\*\*Statistically significant difference (p\<0.001).. Changes in TUG, TUG COG, and TUG MOTOR were all statistically significant (p\<0.001) with moderate effect sizes (Hedges g= 0.59, 0.55, and 0.55 respectively). The mean TUG score was reduced from 13.2 ± 6.9 seconds at baseline to 9.94 ± 3.53 seconds (p\<0.001) after LSVT BIG intervention. The mean TUG COG time was reduced from 16.3 ± 10.5 seconds at baseline to 11.5 ± 6.1 seconds (p\<0.001) after LSVT BIG intervention, and the TUG MOTOR time was similarly reduced from 16.0 ± 9.8 seconds at baseline to 11.7 ± 5.1 seconds (p\<0.001) after LSVT BIG intervention.

TUG COG cost reflects the degree to which the cognitive task of reciting the days of the week backwards caused a deterioration of TUG performance. This value was significantly improved from 21.6% to 14.9% after LSVT BIG intervention (p\<0.05). TUG MOTOR cost reflects the degree to which the motor task of carrying a cup of water caused a deterioration of TUG performance and was calculated using the formula (TUG MOTOR −TUG) / TUG[@r34]^)^. TUG MOTOR cost was improved from 21.8% to 17.8%; however, the value was not statistically significant. Greater than 10% dual task cost has been associated with decreased mobility and decreased functional ability[@r35], [@r36]^)^. After LSVT BIG intervention, the number of subjects who had\>10% dual task cost was significantly decreased for both the motor and cognitive tasks by 44.44% and 44.23%, respectively (p\<0.001) as depicted in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.LSVT BIG intervention substantially decreased TUG MOTOR and TUG COG dual task cost in subjects that initially presented with DTC \>10%. Note that 24 subjects improved their DTC score to within normal limits..

Dual task interference results are depicted visually in [Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Dual task interference is reduced as a result of LSVT BIG intervention. Change scores are z-normalized to eliminate the impact of change score magnitude[@r27]^)^.. As a result of LSVT BIG intervention, a reduction in dual task interference is observed. Cognitive performance is relatively stable as evidenced by a large majority of points being on or slightly above the y-axis. The impact of the cognitive task on mobility performance varies a bit more, but the trend toward mobility scores improving relative to baseline is substantial.

DISCUSSION {#s4}
==========

In previously published studies, LSVT BIG has been suggested to improve gait speed, UPDRS motor scores, TUG performance, endurance, bed mobility, and other functional measures, potentially more so than other exercise programs such as Nordic walking, home exercise programs, and general treadmill training[@r1],[@r2],[@r3], [@r10], [@r37]^)^. However, little research has been conducted on the impact of LSVT BIG on the ability to dual task. The results of this uncontrolled, retrospective study suggests that LSVT BIG intervention may decrease the negative impact of performing a second task on the speed of mobility in persons with PD. Persons with PD demonstrate improvements in their mobility, speed, and performance of both cognitive and motor dual tasks, as indicated by the significant improvements in TUG, TUG COG, TUG MOTOR, and TUG COG cost following LSVT BIG intervention.

Positive functional results have been suggested when using external cueing strategies, cadence matched music, task specific practice (practicing in dual task conditions), and treadmill training to improve gait speed while performing two tasks simultaneously[@r5], [@r6], [@r17],[@r18],[@r19]^)^. However, the majority of these strategies only demonstrated improvements while the cueing interventions were occurring, which may not be feasible for everyday life. The subjects in this study demonstrated improvements in TUG time during a testing session that occurred at least 24 hours after the last formal LSVT BIG treatment session. These sessions did not include an external cueing strategy applied during testing and did not include encouragement by the examiner to apply the self-cues taught in LSVT BIG. This suggests that the treatment benefits may last at least 24 hours beyond a treatment session. Future studies with longer-term follow-up will be necessary to determine whether the effects of LSVT BIG treatment are more permanent.

For people with PD, a TUG score of greater than 11.5 seconds is indicative of increased risk of falls[@r27]^)^. Using this criteria, our subjects' reduction in the mean TUG score from 13.2 seconds to 9.9 seconds post intervention suggests that LSVT BIG intervention reduces falls risk for people with PD. Mean improvement in TUG score was 3.33 ± 4.4 s, which is smaller than the published minimum detectable changes (MDC) for persons with PD for this measure (3.5 s as described by Huang et al.[@r22]^)^ and 4.85 s as described by Dal Bello-Haas et al.[@r38]^)^). It is important to note that the subjects in these two studies were younger and faster than those in our current study. A recent study by Hofheinz applied more stringent sensitivity criteria to determine a cutoff score to identify fallers, suggesting that persons with PD with TUG COG times slower than ten seconds are at a higher risk for falls[@r26]^)^. This criteria would indicate that 72 of our subjects were at risk. 70 of these subjects decreased their TUG COG times from pre to post test and 24 at risk subjects demonstrated TUG COG scores below 10 seconds at post-test, further supporting that fall risk had been reduced. Maranhao-Filho et al. found that persons with PD with a difference between a patient's TUG score and TUG MOTOR score of 4.5 seconds placed them at an increased risk for falls. Based on this criteria, at pre-test nineteen of our subjects were at an increased risk for falls[@r29]^)^. Eighteen of these subjects demonstrated decreased differences at post-test and 14 of these subjects decreased their difference scores to, or below, the 4.5 second cutoff score.

Previous studies have presented mixed results regarding attentional strategies similar to LSVT BIG for improving dual task performance[@r8], [@r17], [@r39]^)^. One explanation for these less than optimal results has been that attentional strategies may add additional cognitive demand to the brain, thereby decreasing the cognitive reserve available for dual tasks[@r8]^)^. It has been suggested that the large training volume, consistent increases in training complexity, emphasis on meaningful tasks, and application of LSVT BIG strategies to a wide variety of tasks brings patients to the point that these attentional strategies become automatic[@r12]^)^. We would argue that the stable cognitive performances demonstrated by the subjects in this study support the hypothesis that the self-cuing/attentional strategies practiced during the LSVT BIG interventions did not decrease the cognitive reserve available to the subjects and that the dramatically improved motor performances support that these strategies were effective.

It is important to consider the limitations of this study. Due to the retrospective cohort study design, no control group was included; therefore, the improvements in dual task performance cannot be conclusively attributed to the LSVT BIG intervention. The study design also makes it difficult to establish the impairment level of the subjects studied because no standardized measure of disease severity was collected. However, by comparing the cohort's TUG scores to studies that reported subjects' TUG score and Hoehn & Yahr (H&Y) scores, it can be inferred that the subjects in this study were similar to those with a H&Y score of 2--3[@r40]^)^. Although the method used in this study for the TUG COG has been validated for use in older adults[@r31]^)^ and in persons with PD[@r30]^)^, it is not consistent with the testing protocol described in the original published version of the TUG COG test[@r32]^)^. Several subjects encountered a ceiling effect on the cognitive and motor secondary tasks, indicating that the secondary tasks may not have been challenging enough to demonstrate the maximal extent to which dual tasking difficulties impacts their daily life. Lastly, due to the lack of data for motor and cognitive tasks performed without a second mobility task, a direct analysis of the impact of performing a mobility task on cognitive or motor performance cannot be drawn.

Future research should focus on higher-level study designs to draw more definitive conclusions about LSVT BIG intervention. Long term retention of gains should also be investigated to determine if LSVT BIG can help decrease the negative impact of movement disorders on dual task performance in patients with PD well after the patient has completed the 16 LSVT BIG sessions. Finally, it may be noteworthy to investigate the effect LSVT BIG has on freezing of gait (FOG), because those that experience FOG have exacerbated gait impairments when performing a dual task. This study suggests that LSVT BIG treatment may have a positive impact on mobility and cognitive performance while performing two tasks simultaneously in persons with Parkinson's disease.
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